menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

Medable Inc.-Logo

Medable

Global cloud platform for decentralized clinical trials.

Metabolon

Biochemical profiling platform that provides analysis of complex biological samples.

Mirvie

Predicts pregnancy complications early by analyzing RNA messages.

Neuron23 Inc-Logo

Neuron23

Biotechnology company focused on developing personalized medicines for genetic disorders.

NewLimit-Logo

NewLimit

Develops epigenetic reprogramming therapies.

NiKang Therapeutics

Specializing in cancer and autoimmune disease therapies.

Nutcracker Therapeutics-Logo

Nutcracker Therapeutics

Uses high-technology engineering and advanced biosynthesis to advance mRNA therapeutics through strategic partnerships with clinical institutions and pharmaceutical/biotech companies.

Obsidian Therapeutics

A biotechnology company specializing in engineered cell therapies, using gene editing technologies to create personalized treatments that improve immune responses and patient outcomes in the fight against cancer and other diseases.

Om1 Inc-Logo

OM1

Uses clinical data and AI to better understand patient outcomes and personalize patient care.

OnKure Therapeutics

Developing innovative cancer therapies, using advanced technology to target specific cancer mechanisms.

Opentrons Labworks Inc-Logo

Opentrons Labworks

A developer of a pipetting robot technology designed to automate experiments.

Orcabio-Logo

Orca Bio

A clinical-stage biotechnology company developing a pipeline of high-precision allogeneic cell therapy products.

Owkin-Logo

Owkin

Biotechnology company using AI to personalize treatment.

Pathai-Logo

PathAI

The leading provider of AI-powered technology for pathology.

Pivot Bio-Logo

Pivot Bio

Developed a new in-field solution to biological nitrogen fixation for farmer, providing daily crop feeding without leaching, volatilization, or denitrification.

PrognomIQ

Develops advanced tests combining proteomic, genomic, and metabolomic data for early disease detection and treatment.

Q32 Bio

Develops biologic therapeutics targeting key immune regulators, aiming to restore balance in autoimmune and inflammatory diseases.

Quanta Therapeutics

Therapeutics for conformational blockade of RAS in cancer.